View Item 

Show simple item record

GABA and benzodiazepine receptors in basal ganglia function

dc.contributor.authorYoung, Anne B.en_US
dc.contributor.authorPan, Helen S.en_US
dc.contributor.authorCiliax, Brian J.en_US
dc.contributor.authorPenney, John B.en_US
dc.date.accessioned2006-04-07T18:26:27Z
dc.date.available2006-04-07T18:26:27Z
dc.date.issued1984-06-29en_US
dc.identifier.citationYoung, Anne B., Pan, Helen S., Ciliax, Brian J., Penney, John B. (1984/06/29)."GABA and benzodiazepine receptors in basal ganglia function." Neuroscience Letters 47(3): 361-367. <http://hdl.handle.net/2027.42/24774>en_US
dc.identifier.urihttp://www.sciencedirect.com/science/article/B6T0G-482RJ1R-1N/2/b4b45fc1597ea919563de07783668fdden_US
dc.identifier.urihttps://hdl.handle.net/2027.42/24774
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=6089057&dopt=citationen_US
dc.description.abstractGABA and its associated benzodiazepine interactions play an important role in basal ganglia function. Distinctive GABA, benzodiazepine and opiate receptor changes occur in response to striatal lesions and in the human neurodegenerative disorder, Huntington's disease (HD). In animal experiments, the in vivo administration of [3H]flunitrazepam labels benzodiazepine receptors and can demonstrate the receptor changes seen after striatal lesions. It should be possible to measure these receptors in vivo in humans using positron-emission tomographic scanning.en_US
dc.format.extent400607 bytes
dc.format.extent3118 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.language.isoen_US
dc.publisherElsevieren_US
dc.titleGABA and benzodiazepine receptors in basal ganglia functionen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelPublic Healthen_US
dc.subject.hlbsecondlevelPsychologyen_US
dc.subject.hlbsecondlevelNeurosciencesen_US
dc.subject.hlbsecondlevelMolecular, Cellular and Developmental Biologyen_US
dc.subject.hlbtoplevelSocial Sciencesen_US
dc.subject.hlbtoplevelScienceen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Neurology, University of Michigan, Ann Arbor, MI 48104, U.S.A.; Department of Pharmacology, University of Michigan, Ann Arbor, MI 48104, U.S.A.en_US
dc.contributor.affiliationumDepartment of Pharmacology, University of Michigan, Ann Arbor, MI 48104, U.S.A.; Department of Neurology, University of Michigan, Ann Arbor, MI 48104, U.S.A.en_US
dc.contributor.affiliationumDepartment of Pharmacology, University of Michigan, Ann Arbor, MI 48104, U.S.A.; Department of Neurology, University of Michigan, Ann Arbor, MI 48104, U.S.A.en_US
dc.contributor.affiliationumDepartment of Pharmacology, University of Michigan, Ann Arbor, MI 48104, U.S.A.; Department of Neurology, University of Michigan, Ann Arbor, MI 48104, U.S.A.en_US
dc.identifier.pmid6089057en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/24774/1/0000198.pdfen_US
dc.identifier.doihttp://dx.doi.org/10.1016/0304-3940(84)90540-8en_US
dc.identifier.sourceNeuroscience Lettersen_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
0000198.pdf
Size:
391.2KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.